Concourse Financial Group Securities, Inc. Options Holdings

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
Neos ETF Trust
PUT
$0
0
Q3 2024
New holding
Neos ETF Trust
CALL
$0
0
Q3 2024
New holding
Neos ETF Trust
PUT
$0
0
Q3 2024
New holding
Neos ETF Trust
CALL
$0
0
Q3 2024
New holding
Neos ETF Trust
PUT
$0
0
Q3 2024
New holding
Neptune Wellness Solutions I
CALL
$0
0
Q3 2024
New holding
Neptune Wellness Solutions I
PUT
$0
0
Q3 2024
New holding
Nerdwallet Inc
CALL
$0
0
Q3 2024
New holding
Nerdwallet Inc
PUT
$0
0
Q3 2024
New holding
Nerdy Inc
CALL
$0
0
Q3 2024
New holding
Net 1 Ueps Technologies Inc
CALL
$0
0
Q3 2024
New holding
Net 1 Ueps Technologies Inc
PUT
$0
0
Q3 2024
New holding
Net Lease Office Properties
CALL
$0
0
Q3 2024
New holding
Net Lease Office Properties
PUT
$0
0
Q3 2024
New holding
Net Power Inc
CALL
$0
0
Q3 2024
New holding
Net Power Inc
PUT
$0
0
Q3 2024
New holding
Netapp Inc
CALL
$0
0
Q3 2024
New holding
Netapp Inc
PUT
$0
0
Q3 2024
New holding
Netease Inc
CALL
$0
0
Q3 2024
New holding
Netease Inc
PUT
$0
0
Q3 2024
New holding
Netflix Inc
CALL
$0
0
Q3 2024
New holding
Netflix Inc
PUT
$0
0
Q3 2024
New holding
Netgear Inc
CALL
$0
0
Q3 2024
New holding
Netgear Inc
PUT
$0
0
Q3 2024
New holding
Netscout Sys Inc
CALL
$0
0
Q3 2024
New holding
Netscout Sys Inc
PUT
$0
0
Q3 2024
New holding
Netsol Technologies Inc
CALL
$0
0
Q3 2024
New holding
Netsol Technologies Inc
PUT
$0
0
Q3 2024
New holding
Netstreit Corp
CALL
$0
0
Q3 2024
New holding
Netstreit Corp
PUT
$0
0
Q3 2024
New holding
Neubase Therapeutics Inc
CALL
$0
0
Q3 2024
New holding
Neubase Therapeutics Inc
PUT
$0
0
Q3 2024
New holding
Neumora Therapeutics Inc.
CALL
$0
0
Q3 2024
New holding
Neumora Therapeutics Inc.
PUT
$0
0
Q3 2024
New holding
Neurobo Pharmaceuticals Inc
CALL
$0
0
Q3 2024
New holding
Neurobo Pharmaceuticals Inc
PUT
$0
0
Q3 2024
New holding
Neurocrine Biosciences Inc
CALL
$0
0
Q3 2024
New holding
Neurocrine Biosciences Inc
PUT
$0
0
Q3 2024
New holding
Neurogene Inc
CALL
$0
0
Q3 2024
New holding
Neurogene Inc
PUT
$0
0
Q3 2024
New holding
Neuronetics Inc
CALL
$0
0
Q3 2024
New holding
Neuronetics Inc
PUT
$0
0
Q3 2024
New holding
Neuroone Med Technologies CO
CALL
$0
0
Q3 2024
New holding
Neuroone Med Technologies CO
PUT
$0
0
Q3 2024
New holding
Neuropace Inc
CALL
$0
0
Q3 2024
New holding
Neuropace Inc
PUT
$0
0
Q3 2024
New holding
Nevro Corp
CALL
$0
0
Q3 2024
New holding
Nevro Corp
PUT
$0
0
Q3 2024
New holding
New Fortress Energy Inc
CALL
$0
0
Q3 2024
New holding

Summary

  • Portfolio
  • No. of Stocks 22,037
  • Current Value $1.64 Billion
  • Prior Value $1.56 Billion
  • Filing
  • Period Q3 2024
  • Filing Date October 10, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9,194 stocks
  • Additional Purchases 651 stocks
  • Sold out of 170 stocks
  • Reduced holdings in 988 stocks
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email